Lindsey Brown

FDA investigator · also recorded as Ee Lindsey Brown

Appears on 4 documents from 2017 to 2024, most often at sites in Belgium. Most often cites general requirements (21 CFR 211.160).

4
Documents on file
6.0
Observations per 483
2017
First seen
2024
Most recent

What they cite most

From 24 observations

Activity by year

2017: 1, 2021: 1, 2023: 1, 2024: 1

Where

Belgium 1 · Denmark 1 · India 1 · Texas 1

Is Lindsey Brown coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

4 documents, newest first
FirmOpen
483 Novo Nordisk A/SMar 25, 2024 · Kalundborg, Denmark
483 FUJIFILM Diosynth Biotechnologies Texas, LLCJun 7, 2023 · College Station, Texas
483 Catalent Belgium S.AOct 26, 2021 · Brussels, Belgium
483 Biocon LimitedApr 7, 2017 · Bangalore, India

About this profile

What does Lindsey Brown inspect?

Lindsey Brown appears on 4 documents on file covering 4 sites, most often in Belgium.

What do they cite most often?

21 CFR 211.160 (general requirements), followed by 21 CFR 211.100 and 21 CFR 211.113.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Lindsey Brown is dated Mar 25, 2024.